Kariv Tomer 4
4 · Keros Therapeutics, Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Kariv Tomer
Director10% Owner
Transactions
- Award
Stock Options (right to buy)
2022-06-01+8,293→ 8,293 totalExercise: $32.95Exp: 2032-05-31→ Common Stock (8,293 underlying)
Footnotes (1)
- [F1]The option shall vest in equal quarterly installments over the 12 months following the date of grant, provided that the grant will in any case be fully vested on the date of Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.